[Comparative study of the expression of p53, Ki-67, bcl-2 and CK20 in superficial transitional carcinoma of the bladder: correlation with recurrence, histological grade, and clinical stage].

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Actas Urológicas Españolas

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 14587233
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of nuclear p53 over-expression with clinical and histopathological features of transitional cell bladder cancer

  2006cited by this paper
• Bcl-2 and p53 overexpression as associated risk factors in transitional cell carcinoma of the bladder

  2006cited by this paper
• Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer

  2004cited by this paper
• Immunohistochemical determination of p53 overexpression

  2004cited by this paper
• Multivariate analysis of survival, recurrence, progression and development of mestastasis in T1 and T2a transitional cell bladder carcinoma

  2002cited by this paper
• [Coordinated expression of cytokeratin 7 and 20 in transitional carcinoma of the bladder: diagnostic usefulness].

  2002cited by this paper
• Comparison of the WHO/ISUP Classification and Cytokeratin 20 Expression in Predicting the Behavior of Low-Grade Papillary Urothelial Tumors

  2001cited by this paper
• Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases

  2000cited by this paper
• The role of bcl-2, p53, and ki-67 index in predicting tumor recurrence for low grade superficial transitional cell bladder carcinoma.

  2000cited by this paper
• [Molecular biology in bladder cancer].

  2000cited by this paper
• [DNA ploidy determination with flow cytometry, Ki-67 index, and overexpression of p53 protein in 121 T1 superficial bladder carcinoma. Retrospective study. Correlation with classic variables].

  2000cited by this paper
• Prognostic value of the proliferative index determined by Ki-67 immunostaining in superficial bladder tumors.

  1999cited by this paper
• Cytokeratin expression patterns in normal and malignant urothelium: a review of the biological and diagnostic implications.

  1999cited by this paper
• Expression of cytokeratin 20 redefines urothelial papillomas of the bladder.

  1999cited by this paper
• Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.

  1999cited by this paper
• Reciprocal expression of bcl-2 and p53 oncoproteins in urothelial dysplasia and carcinoma of the urinary bladder

  1998cited by this paper
• Comparative Analysis of MiB1 and p53 Expression in Human Bladder Tumors and Their Correlation with Cancer Progression

  1998cited by this paper
• Invasion of the bladder by transitional cell carcinoma

  1998cited by this paper
• Expression of bcl-2 and bcl-X in bladder cancer.

  1998cited by this paper
• bcl-2/bax expression and p53 gene status in human bladder cancer: relationship to early recurrence with intravesical chemotherapy after resection.

  1998cited by this paper
• The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

  1998cited by this paper
• p53 and MDM2 in the development and progression of bladder cancer.

  1997cited by this paper
• Nuclear accumulation of mutant p53 protein: a possible predictor of failure of intravesical therapy in bladder cancer.

  1997cited by this paper
• Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

  1997cited by this paper
• Expression of bcl-2 and p53 oncoproteins in schistosomiasis-associated transitional and squamous cell carcinoma of urinary bladder.

  1997cited by this paper
• PCNA and p53 in Urinary Bladder Cancer: Correlation with Histological Findings and Prognosis

  1997cited by this paper
• Apoptosis and immunohistochemical bcl‐2 expression in colorectal adenomas and carcinomas: Aspects of carcinogenesis and prognostic significance

  1996cited by this paper
• Relationship of p53 and bcl-2 to prognosis in muscle-invasive transitional cell carcinoma of the bladder.

  1996cited by this paper
• Expression of the apoptosis suppressing bcl‐2 protein in transitional cell bladder tumours

  1996cited by this paper
• Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.

  1995cited by this paper
• Patterns of p53, erbB-2, and EGF-r expression in premalignant lesions of the urinary bladder.

  1995cited by this paper
• Expression of the apoptosis‐suppressing protein Bcl‐2 in non‐melanoma skin cancer

  1995cited by this paper
• Bcl‐2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland

  1994cited by this paper
• Accumulation of nuclear p53 and tumor progression in bladder cancer.

  1994cited by this paper
• Over‐expression of p53 nuclear oncoprotein in transitional‐cell bladder cancer and its prognostic value

  1993cited by this paper
• Monoclonal antibodies against recombinant parts of the Ki‐67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave‐processed formalin‐fixed paraffin sections

  1992cited by this paper
• Prognostic factors in bladder carcinoma: Histologic parameters and expression of a cell cycle‐related nuclear antigen (Ki‐67)

  1992cited by this paper
• Cell proliferation and bladder tumor promotion.

  1991cited by this paper
• Cell proliferation of human bladder tumors determined by BrdUrd and Ki-67 immunostaining.

  1991cited by this paper
• Growth fractions of transitional cell carcinomas of the bladder defined by the monoclonal antibody Ki-67.

  1990cited by this paper

• The value of BCL2 and CK20 expression in predicting behavioral patterns of bladder cancer, a cross sectional study

  2022cites this paper
• Clinical Use of Tumor Markers for the Detection and Prognosis of Bladder Carcinoma: A Comparison of CD44, Cytokeratin 20 and Survivin.

  2016cites this paper
• External validation of FXYD3 and KRT20 as predictive biomarkers for the presence of micrometastasis in muscle invasive bladder cancer lymph nodes.

  2015cites this paper
• Superficial papillary urothelial neoplasms of the bladder (PTA E PT1): correlation of expression of P53, KI-67 and CK20 with histologic grade, recurrence and tumor progression.

  2012cites this paper
• [Prognostic value of E-cadherina, beta catenin, Ki-67 antigen and p53 protein in the superficial bladder tumors].

  2006cites this paper
• Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 cases

  2006cites this paper